Search filters

Filters
Clear All

Phase

  • 1
  • 2
  • 2
  • 5
  • 1
  • 1
  • 4

Found 5 Rash trials

A listing of Rash medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
All genders
Phase 2
Interventional
This study investigates the treatment of acute graft-versus-host disease (GVHD).The study evaluates the effectiveness and safety of using ruxolitinib as a treatment for GVHD.Who can participate: Adults aged 18 and older with acute GVHD after allogeneic hematopoietic cell transplant can participate. Participants must not have had prior systemic acute GVHD …
UPCC 30213 The Cancer of the Pancreas Screening-5
18 years or above
All genders
Phase 3
Interventional
This study investigates screening methods for pancreatic cancer in individuals who are at high risk due to genetic factors or family history. The purpose of this study is to better understand the effectiveness of these screening methods in detecting early signs of pancreatic cancer.Participants in this study will undergo procedures …
18 years - 99 years
All genders
Observational
To understand how rare human inflammatory skin diseases develop and work, we will collect your human tissue from lesional (diseased and affected) and non-lesional (normal, unaffected) skin, as well as blood, cheek swab(s), photographs of the biopsy sites or rash, and medical information.
99 years or below
All genders
Our goal is to identify markers which can predict response to therapy in patients with dermatomyositis, systemic sclerosis, lupus erythematosus, morphea, eosinophilic fasciitis, and other immune-mediated cutaneous and rheumatic diseases. To collect human tissue from lesional and non-lesional skin, as well as blood, cheek swabs, photographs of biopsy site(s) or …
18 years or above
Female
Phase 3
Interventional
This study investigates the effectiveness of adding investigational medication combinations to the usual chemotherapy in patients with HER2 positive endometrial cancer. The investigational medications, which include monoclonal antibodies like trastuzumab and pertuzumab, target HER2 receptors on cancer cells to block signals for growth and potentially mark the cells for destruction …